Please login to the form below

Not currently logged in
Email:
Password:

US pharma

This page shows the latest US pharma news and features for those working in and with pharma, biotech and healthcare.

New ABPI president pledges closer collaboration with NHS

New ABPI president pledges closer collaboration with NHS

New ABPI president pledges closer collaboration with NHS. UK pharma body appoints a president and vice president for the first time. ... Writing on behalf of 10 US-headquartered pharma companies, he said that “the UK pharmaceutical industry and the

Latest news

More from news
Approximately 8 fully matching, plus 479 partially matching documents found.

Latest Intelligence

  • A new era of smart pharma A new era of smart pharma

    A new era of smart pharma. How smarter pharmaceuticals and pharmacovigilance are transforming healthcare. ... Pharma companies are having to adapt and innovate to keep pace with the vast changes brought about by digital technology.

  • Six degrees of participation Six degrees of participation

    The era of Participatory Medicine - aka collaborative care or shared decision-making - is upon us, and fittingly for pharma, it’s the taking part that counts. ... UK, as well as the Head of Digital and therapeutic heads from within the pharma client

  • Health on instalment Health on instalment

    Health on instalment. Can US-style financial engineering underwrite ultra-expensive gene therapies? ... Given the animus that exists among US pharma stakeholders, reactions so far have been remarkably conciliatory.

  • Pharma deals continue to slide Pharma deals continue to slide

    Are deals being delayed or prevented by macroeconomic factors? Pfizer and some other big pharma companies are using uncertainty about US tax reform and Brexit and high company valuations as reasons ... 1, 410 (upfront 80). WuXi Biologics and Gloria

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    Being realistic, securing free trade deals with major economies such as the US, Japan and China could take a decade or more.

More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

  • Targovax appoints Michael Bogenstaetter as chief business officer Targovax appoints Michael Bogenstaetter as chief business officer

    Øystein Soug, chief executive officer of Targovax, said: “Bogenstaetter’s extensive experience of business development and corporate strategy in the biotech and pharma industry will be indispensable to us.”.

  • Lighthouse Medical Communications appoints Andy Willmer as managing director Lighthouse Medical Communications appoints Andy Willmer as managing director

    Lucid Group subsidiary Lighthouse Medical Communications US has appointed Andy Willmer to head up its operations. ... Dennis O’Brien, CEO and co-founder of  Lucid, said: “Andy is a great fit with the team – and his history and experience in US and

  • Envigo appoints Lizanne Muller as president, EMEA operations Envigo appoints Lizanne Muller as president, EMEA operations

    Envigo appoints Lizanne Muller as president, EMEA operations. And Craig Boyd joins from Mayne Pharma as chief commercial officer. ... He has more than 20 years’experience in various global pharmaceutical markets and was previously executive vice

  • XenoGesis appoints business development consultant XenoGesis appoints business development consultant

    XenoGesis appoints business development consultant. Sabrina Mogle will spearhead CRO’ s US growth. ... Bringing expertise in business and corporate development in the biotech and pharma industries, Mogle will spearhead XenoGesis' US business

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    Natasha Giordano joins PLx Pharma. She replaces Ronald Zimmerman as president and chief executive officer. ... Giordano has also been appointed to the US specialty pharma company's board of directors, of which her predecessor Ronald Zimmerman will remain

More from appointments
Approximately 0 fully matching, plus 39 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics